Daily Aspirin Fails to Lower CV Risk in Long-term, Primary Prevention Print E-mail
Written by FHI's Week in Review   
Monday, 27 August 2018 12:01
Somewhat surprising news broke over the weekend. Here's an excerpt from Medscape:
Aspirin at a daily dose of 100 mg was not seen to reduce the long-term risk for cardiovascular (CV) or cerebrovascular events in a trial that randomly assigned more than 12,000 nondiabetic adults with multiple CV risk factors but no history of CV events. Nor was the risk for stroke reduced.
Read more in the current issue of Week in Review>>

Website design, development, and hosting provided by